Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection

被引:4
|
作者
Xu, Yang [1 ]
Han, Huimin [1 ]
Cao, Wei [1 ]
Fu, Hongxing [1 ]
Liu, Yang [1 ]
Yan, Li [2 ]
Qin, Tingting [1 ]
机构
[1] Wuhan Third Hosp, Dept Integrated Tradit Chinese & Western Med, 241 Pengliuyang Rd, Wuhan 430060, Peoples R China
[2] Wuhan Third Hosp, Dept Tradit Chinese Med, 241 Pengliuyang Rd, Wuhan 430060, Peoples R China
关键词
Primary hepatocellular carcinoma; operation; recurrence; prediction model; CANCER; ASCITES;
D O I
10.21037/jgo-22-1303
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In recent years, nomogram prediction models have been widely used to evaluate the prognosis of various diseases. However, studies in primary hepatocellular carcinoma (HCC) are limited. This study sought to explore the risk factors of recurrence of patients with primary HCC after surgical resection and establish a nomogram prediction model. Methods: The data of 424 patients with primary HCC who had been admitted to the Wuhan Third Hospital were retrospectively collected. The patients were followed-up for 5 years after surgery. The patients were divided into the recurrence group (n=189) and control group (n=235) according to whether the cancer recurred after surgery. The differences in the clinical characteristics between the two groups were analyzed. The risk factors of recurrence after surgical resection of primary HCC were also analyzed, and a prediction model was then established using R4.0.3 statistical software. Results: There were significant statistical differences between the two groups in terms of the tumor size, systemic immune-inflammation (SII) index, the number of lesions, tumor differentiation degree, ascites, vascular invasion, and portal vein tumor thrombus (P<0.05). The multivariate regression analysis showed that multiple foci, poorly differentiated tumors, ascites, vascular invasion, and portal vein tumor thrombus were risk factors for the recurrence of primary HCC in patients after surgical resection (P<0.05). The data set was randomly divided into a training set and verification set. The sample size of the training set was 297, and the sample size of the verification set was 127. The area under the receiver operating characteristic (ROC) curve of the training set was 0.866 [95% confidence interval (CI): 0.824-0.907], and the area under the ROC curve of the validation set was 0.812 (95% CI: 0.734-0.890). The Hosmer-Lemeshow Goodness-of-Fit Test was used to test the model with the validation set (chi(2)=11.243, P=0.188), which indicated that the model had high value in predicting the recurrence of primary HCC after surgical resection. Conclusions: This model had high value in predicting the recurrence of primary HCC in patients after surgical resection. This model could assist clinicians to assess the prognosis of patients. Intensive treatment for high-risk patients might improve the prognosis of patients.
引用
收藏
页码:278 / 286
页数:9
相关论文
共 50 条
  • [31] Establishment of a novel integrated model for prediction of hepatocellular carcinoma recurrence after liver transplantation
    Ng, K. T. P.
    Luo, R. B.
    Liu, J.
    Lam, L. Y. F.
    Yeung, O. W. H.
    Liu, H.
    Liu, X. B.
    Lo, C. M.
    Man, K.
    TRANSPLANTATION, 2019, 103 (08) : 68 - 69
  • [32] Validation of the -fetoprotein Model for Hepatocellular Carcinoma Recurrence After Transplantation in an Asian Population
    Rhu, Jinsoo
    Kim, Jong Man
    Choi, Gyu Seong
    Kwon, Choon Hyuck David
    Joh, Jae-Won
    TRANSPLANTATION, 2018, 102 (08) : 1316 - 1322
  • [33] Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection
    Xu, Yue
    Yao, Xiaoqin
    Li, Jinmei
    Zhang, Guoyuan
    Luo, Guangcheng
    Wang, Qiang
    CANCER MEDICINE, 2023, 12 (12): : 13329 - 13341
  • [34] Development and validation of a risk score for predicting mortality after resection of primary hepatocellular carcinoma
    Zhou, Xiang
    Cai, Bin-Bin
    Hou, Xiang-Qing
    Kang, Xing-Kai
    Xu, Xiang-Xiang
    Wang, Wei-Ming
    AGING-US, 2020, 12 (12): : 11878 - 11892
  • [35] Predictive factors for the distant recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma
    Fuke, H
    Yamanaka, Y
    Yamamoto, N
    Nakano, T
    Shiraki, K
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S114 - S114
  • [36] A Prognostic Model and Treatment Strategy for Intrahepatic Recurrence of Hepatocellular Carcinoma after Curative Resection
    Yuzo Umeda
    Hiroaki Matsuda
    Hiroshi Sadamori
    Hiroyoshi Matsukawa
    Takahito Yagi
    Toshiyoshi Fujiwara
    World Journal of Surgery, 2011, 35 : 170 - 177
  • [37] Survival and Treatment Use after Hepatocellular Carcinoma Recurrence after Resection
    Whitham, Zach
    Yopp, Adam C.
    Mansour, John C.
    Porembka, Matthew R.
    Polanco, Patricio M.
    Zeh, Herbert J., III
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S290 - S290
  • [38] A Prognostic Model and Treatment Strategy for Intrahepatic Recurrence of Hepatocellular Carcinoma after Curative Resection
    Umeda, Yuzo
    Matsuda, Hiroaki
    Sadamori, Hiroshi
    Matsukawa, Hiroyoshi
    Yagi, Takahito
    Fujiwara, Toshiyoshi
    WORLD JOURNAL OF SURGERY, 2011, 35 (01) : 170 - 177
  • [39] A prognostic model for early recurrence prediction in hepatocellular carcinoma after liver resection.
    Ruan, Dan-Yun
    Li, Yang
    Jiang, Nan
    Lin, Ze-Xiao
    Wan, XiangBo
    Li, Xing
    Wu, Xiang-Yuan
    Chen, Guihua
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Hepatocellular Carcinoma: Should We Consider Liver Transplantation at the Time of Recurrence After Primary Resection?
    Aroz, Sandra Garcia
    Vachharajani, Neeta
    Doyle, Majella
    Chapman, William
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 78 - 78